Technology implementation risk

USNRC s policy for implementing risk-informed regulation was expressed in the 1995 policy statement on the use of probabilistic risk assessment (PRA) methods in nuclear regulatory activities. The policy statement says The use of PRA technology should be increased in all regulatory matters to the extent supported by the state-of-the-art in PRA methods and data and in a manner that complements the NRC s deterministic approach and supports the NRC s traditional defence-in-depth philosophy. 

An assessment of gaps and technical risks in sophisticated technology implementation efforts in complex operations A case from an integrated production monitoring environment... 

Risk Homeostasis The theory that an operator will attempt to maintain a stable perception of risk following the implementation of new technology that increases the safety of a human-machine system. The theory predicts that operators will take greater risks where more safety devices are incorporated into the system. 

Currently, physicians and patients determine the demand for pharmaceuticals and employers and insurers assume the risk and cost. As the price of new health care technologies escalates, payers will design and implement strategies to share risk and cost. Defined employer contributions, increased patient cost sharing, and benefit exclusions will be used to help control utilization and cost. In this environment, value-based assessments will be crucial to the adoption of any technological innovation. It is reasonable to expect public and private coverage for new therapies if evidence is provided regarding the costs and consequences of treatment. However, social and ethical dilemmas will certainly arise as therapies whose costs exceed their benefits are debated in the public arena. 

Thus, there is an urgent need to protect the Caspian environment in order to maintain it for future generations. Continued economic development, improved regional cooperation, and the implementation of modern technology will be required in order to improve the state of the environment in and around the Caspian Sea in coming years and decrease accordingly the environmental risk values. 

Most project risk comes from two sources business requirements and technology infrastructure. It is common for a project team to evaluate complexity based mostly on the business requirements—the problem domain itself—and vastly underestimate the effort it will take to implement all the plumbing and supporting pieces that are not domain-specific. 

In addition to the control system vulnerabilities mentioned earlier, several factors have contributed to the escalation of risk to control systems, including (1) the adoption of standardized technologies with known vulnerabilities, (2) the connectivity of control systems to other networks, (3) constraints on the implementation of existing security technologies and practices, (4) insecure remote connections, and (5) the widespread availability of technical information about control systems. 

The innovations described are, however, beyond fulfilling limit values. Reducing waste costs, technology leadership and the image gain related to this are the objectives of the pioneering enterprises, which implement environmentally compatible innovations in this area despite high investments and risks. 

The term substance of very hi h concern, abbreviated SVHC, is associated with a new process that was introduced to the European chemicals policy through the implementation of REACH the authorization process. This procedure aims (1) to encourage the substitution of substances of very high concern with less harmful substances or alternative technologies and (2) assure the proper control of risks arising from SVHC s. A substance being subject to authorization must principally not be used or placed on the market for any use within the European Union. However, specific uses of an authorized substance may be excluded from this general prohibition if, for example, they are a priori exempted from authorization or if the manufacturer, importer, or downstream user successfully applied for their authorization. The authorization process is laid down in REACH Articles 55-66 and may be initiated by the ECHA on behalf of the European Commission or by EU member state competent authorities. Substances which are subject... 

---